Fund shareholders of ENGENE THERAPEUTICS INC
ISIN CA29286X1015 · Canada
- Fund shareholders
- 2
- Of which ETFs
- 1 1 other fund
- Value held
- 3.8M $
2 tracked funds declare this company. So these figures do not say who owns it.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 486,579 | 3.5M $ | 0.34 % | as of Apr 30, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 32,625 | 237.2K $ | 0.64 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 0.64 % | as of Apr 30, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 0.34 % | as of Apr 30, 2026 ↗ |
Cite this page
Titelia. "Fund shareholders of ENGENE THERAPEUTICS INC". https://titelia.com/en/stocks/engene-therapeutics-inc-CA29286X1015